Myocardial infarction and arterial thrombosis in severe (homozygous) FXII deficiency: No apparent causative relation

30Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Twenty-one patients (12 female and 9 male) with severe (homozygous) factor XII (FXII) deficiency and 58 (32 female and 26 male) with heterozygous FXII deficiency were observed for an average 16.2 years. No patient with homozygous FXII deficiency experienced myocardial infarction or any other arterial thrombosis. The same was true for heterozygotes. The cases of FXII deficiency and arterial thrombosis reported in the literature were evaluated. In every instance, associated risk factors were present that could justify the arterial thrombosis. Dyslipidemia, hypertension, smoking, and diabetes mellitus were the most frequent findings. The examination of the few papers that dealt with the prevalence of arterial thrombosis in patients with severe FXII deficiency showed that only 1 patient of 61 experienced myocardial infarction. In conclusion, it seems that the role of FXII deficiency in the pathogenesis of arterial thrombosis is minor.

Cite

CITATION STYLE

APA

Girolami, A., Morello, M., Girolami, B., Lombardi, A. M., & Bertolo, C. (2005). Myocardial infarction and arterial thrombosis in severe (homozygous) FXII deficiency: No apparent causative relation. Clinical and Applied Thrombosis/Hemostasis, 11(1), 49–53. https://doi.org/10.1177/107602960501100105

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free